ExploreInterventionHypericum perforatum
Intervention

Hypericum perforatum

Also known as: Goat weed Hypericum perforatum Hypericum perforatum (St. John's Wort) 900-1500 mg/day Hypericum perforatum (organism) Hypericum perforatums John's Wort, Saint John's Wort, St. Johns Wort, Saint Johns Wort, St. Johnswort, Saint Johnswort, St. Klamath weed +17 more
3 findings 1 paper 3 related entities View in graph →

Related entities

conditions
outcomes
studys

Findings (27)

None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=
None
improvement

In the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re

Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218

Size: somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=

Papers (1)